Mai O. Kadry | Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Mai O.Kadry | Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Mai O.Kadry,National Research Center, Egypt

Dr. Mai Osman Mohamed Kadry is a distinguished biochemistry researcher at the Therapeutic Chemistry Department, National Research Centre, Egypt. With a Doctorate in Biochemistry from Cairo University (2016), her work focuses on oxidative injury, nanotoxicity, and cancer therapy. She has published extensively in high-impact journals on topics like antioxidant effects, stem cell therapies, and metabolic disorders. Dr. Kadry has also contributed to academia, teaching pharmacognosy at 6th October University. Skilled in advanced techniques like PCR, HPLC, and ELISA, she actively participates in groundbreaking nanobiotechnology research projects. Dr. Kadry is committed to advancing therapeutic strategies for critical diseases. 📚🧬

Publication Profile

Scopus

Academic and Professional Experience 🌟🎓

Assist. Prof. Dr. Mai O. Kadry has accumulated valuable experience in academia and research. She served as a pharmacognosy instructor at the Faculty of Pharmacy, 6th October University, Cairo, Egypt (2003–2004), where she effectively delivered courses on natural products and their therapeutic applications. Dr. Kadry also contributed as a staff member focused on development and quality enhancement, aligning with the standards of the National Commission for Academic Accreditation. Her dedication to education and quality assurance reflects her commitment to fostering academic excellence and professional growth in pharmaceutical sciences. 📚🔬

 

Educational Background 🎓📘

Assist. Prof. Dr. Mai O. Kadry boasts a strong academic foundation in pharmaceutical sciences. She earned her Doctorate in Biochemistry from the Faculty of Pharmacy, Cairo University, in 2016, with a thesis on the “Amelioration of Nano-Sized Titanium Dioxide-Induced Oxidative Injury in Mice by Some Antioxidants.” She obtained her Master’s degree in Pharmaceutical Sciences from Helwan University in 2008, focusing on the synergistic effects of phytic and catechin on carbon tetrachloride-induced damage in rats. Dr. Kadry completed her B.Sc. in Pharmaceutical Science at Ain Shams University in 2003, graduating with honors. She also attended English language schools, enhancing her global communication skills. 🌟🔬

 

Training 🧬📚

Assist. Prof. Dr. Mai O. Kadry has undergone extensive training in various scientific disciplines. She completed courses in Biostatistics (November 2016) and Bioinformatics (January 2017) at the National Research Centre. Earlier, she gained expertise in Scientific Typewriting Bases (March 2007) and Occupational Health and Safety (June 2009). Additionally, she mastered Protein Electrophoresis through a four-month course in 2006. Dr. Kadry enhanced her practical skills with hands-on training at Al-Borg Clinical Laboratory, focusing on PCR techniques for detecting HBV and HCV at the Theodor Bilharz Research Institute. Her comprehensive training equips her with valuable laboratory and analytical skills. 🔬🧪

 

Research Focus 🧪🧠🧬

Assist. Prof. Dr. Mai O. Kadry focuses on cutting-edge biomedical research, emphasizing toxicity, cancer therapy, and molecular biology. Her work explores inflammatory mediators, DNA damage, and therapeutic approaches in liver, brain, and nephrotoxicity contexts. She investigates autophagy, necroptosis, and novel strategies like resveratrol nano-formulations for ovarian cancer. Dr. Kadry also studies molecular pathways in gastric and prostate cancers, including miRNA-lncRNA signaling and CRISPR-Cas9 applications. Other interests involve genetic mutations in leukemia, drug-delivery systems, and nanotechnology for breast cancer. Her contributions bridge diagnostics, therapeutic innovations, and cellular mechanisms in oncology and toxicology. 🔬✨

 

Publication Top Notes

  • Inflammatory mediators-induced DNA damage in liver and brain injury: Therapeutic approach of 5-Methoy-N-acetyltryptamine – 2024, Toxicology Reports 🧬
  • Necroptosis and autophagy in cisplatinum-triggered nephrotoxicity: Novel insights regarding prognostic and diagnostic potential – 2024, Toxicology Reports 🧪
  • Resveratrol-based nano-formulations as a therapeutic strategy for ovarian carcinoma: Autophagy and SIRT-1 signaling – 2024, Cancer Nanotechnology 💊
  • miR-122-IGF-1R signaling allied with dysregulated lncRNA MALAT-1 in gastric carcinoma – 2024, Toxicology Reports 🔬 (Cited by: 1)
  • Reciprocal crosslink among MeCP2/BDNF/CREB signaling in autism spectrum disorder – 2024, Toxicology Reports 🧠
  • CRISPR-Cas9 genome and lncRNAs for prostate cancer therapy via liposomal compounds – 2024, PLoS ONE 🧬 (Cited by: 1)
  • Collaboration of Hprt/K-RAS/c-Myc mutation in T-lymphocytic leukemia oncogenesis – 2024, Future Science OA 🧪 (Cited by: 1)
  • Thioctic acid shield against lipopolysaccharide depression and endoplasmic stress – 2024, Future Science OA 🧫
  • Titanium dioxide nanostructure-loaded Adriamycin in breast cancer therapy – 2024, Future Science OA 🎗️ (Cited by: 1)
  • Alleviation of doxorubicin adverse effects via drug-delivery systems – 2024, Therapeutic Delivery 🚑

 

Workisa Chala Bulto | Molecular Characterization | Best Researcher Award

Posted on by ScienceFather

Mr. Workisa Chala Bulto | Molecular Characterization | Best Researcher Award

Mr. Workisa Chala Bulto, National Veterinary Institute, Ethiopia

Evaluation of Mr. Workisa Chala Bulto for the Best Researcher Award

Publication profile

Professional Experience

Mr. Workisa has extensive experience in the veterinary field, currently serving as a Senior Laboratory Officer at the National Veterinary Institute (NVI) of Ethiopia since May 2017. His responsibilities include performing quality control activities to ensure the production of high-quality vaccines. Prior to this, he was a Laboratory Animals Health Officer at NVI, where he managed the health of laboratory animals used for vaccine safety trials. His earlier roles include serving as a Research Assistant at the Ethiopian Institute of Agricultural Research and as a Development Agent in Guduru woreda, focusing on animal science training.

Educational Background

Mr. Workisa holds a Master of Veterinary Science (MVSc) in Veterinary Microbiology from Addis Ababa University, with his thesis focusing on the outbreak investigation and molecular detection of Lumpy Skin Disease Virus in cattle. He also earned a Bachelor of Veterinary Science (BVSc) from Haramaya University, graduating with high distinction (CGPA=3.89), and a Diploma in Animal Science from Alage ATVET College, also with very high distinction (CGPA=3.93).

Skills and Certifications

Mr. Workisa has obtained various certifications in areas such as Biologicals GMP Inspection, risk management, quality management systems, and current good manufacturing practices (cGMP). His training also includes scientific report writing, experimental design, and sheep reproduction techniques.

Research and Publications

Mr. Workisa has contributed to several research projects, including studies on the seroprevalence of small ruminant brucellosis and the effect of improved feeding management on Afar bulls. His recent work includes an unpublished study on the molecular detection of the Lumpy Skin Disease Virus.

Publication Top Notes

  • 🦠📅 2024 – “Outbreak Investigation, Isolation, and Molecular Characterization of Lumpy Skin Disease Virus in Cattle from North West Oromia Region, Ethiopia” – Veterinary Medicine International | DOI: 10.1155/2024/6038724
  • 🧪🐑📅 2015 – “Seroprevalence of Small Ruminant Brucellosis in Werer Agricultural Research Center, Afar Region, North East Ethiopia” – Academia Journal of Microbiology Research
  • 🐂🍖📅 Date not specified – “Effect of Improved Feeding Management on Body Weight Gain and Carcass Characteristics of Afar Bulls for Export Market” – International Journal of Animal Science

Conclusion

Mr. Workisa Chala Bulto’s dedication to veterinary research, his role in vaccine quality control, and his contributions to improving animal health in Ethiopia position him as a strong candidate for the Best Researcher Award. His background in veterinary microbiology, combined with his practical experience and commitment to scientific excellence, makes him well-suited for this recognition.